Download Library

Document Type

Effect of AR-13324 on episcleral venous pressure (EVP) in Dutch Belted rabbits (Presented at Association for Research in Vision and Ophthalmology, 2014)

Double-masked, randomized, dose-response study of AR-13324 Ophthalmic Solution compared to latanoprost in patients with elevated intraocular pressure (Presented at American Glaucoma Society, 2014)

Code of Business Conduct and Ethics

First in Human Clinical Study of a Novel Dual Mechanism Compound (AR-13324) for the Lowering of IOP in Glaucoma and Ocular Hypertension (Presented at Association for Research in Vision and Ophthalmology, 2013)

Discovery and SAR of a Class of Ocularly-active Compounds Displaying a Dual Mechanism of Activity for the Treatment of Glaucoma (Presented at Association for Research in Vision and Ophthalmology, 2012)

IOP-lowering efficacy and tolerability of AR-13324, a dual mechanism kinase inhibitor for the treatment of glaucoma (Presented at Association for Research in Vision and Ophthalmology, 2012)